Company / Interest Expense per Share
Immunome Inc. Interest Expense per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.06
FY2024
5-year range
-$0.00 / $0.06
FY2020-FY2024
Trend
+15177.5%
vs FY2023
Sector context
#31 of 43
Health Care
What the data says
Interest Expense per Share changed +15178% YoY in FY2024, a notable deviation from the 5-year average annual change of +3058%.
Based on SEC 10-K filings.
0.06 in FY2024 with a 5-year CAGR of +8.4%.
Increased from $0.00 to $0.06 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +8.4%
- 10-Year CAGR
- -
Sector benchmark
#13 of 43 in Health CareTop 28% of 43This company $0.06 Sector average $9.80
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2024, interest expense per share increased 15177.5% year-over-year.
- Ranks #31 out of 43 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 4.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.06 | +15177.5% |
| FY2023 | $0.00 | -0.0% |
| FY2022 | $0.00 | +147.6% |
| FY2021 | -$0.00 | +92.3% |
| FY2020 | -$0.01 | -126.7% |
| FY2019 | $0.04 | - |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026